CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

UBS Adjusts Price Target on Acadia Healthcare to $39 From $31, Maintains Buy Rating

Positive
AI Analysis

Summary

UBS raised its price target on Acadia Healthcare from $31 to $39 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
analyst_noteprice_target_increaserating_maintained
Related Companies

Read the original article

Published by yahoo_finance on July 9, 2026 1:42 PM

Read Original